NCT00897533View on ClinicalTrials.gov

Development of a Model to Predict Progression-Free Survival After Erlotinib in Patients With Non-Small Cell Lung Cancer

CompletedOBSERVATIONAL
Enrollment

137

Participants

Timeline

Start Date

April 13, 2007

Primary Completion Date

April 13, 2008

Study Completion Date

April 13, 2008

Conditions
Lung Cancer
Interventions
GENETIC

gene mapping

GENETIC

polymorphism analysis

OTHER

diagnostic laboratory biomarker analysis

OTHER

immunohistochemistry staining method

All Listed Sponsors
collaborator

National Cancer Institute (NCI)

NIH

lead

ECOG-ACRIN Cancer Research Group

NETWORK

NCT00897533 - Development of a Model to Predict Progression-Free Survival After Erlotinib in Patients With Non-Small Cell Lung Cancer | Biotech Hunter | Biotech Hunter